Review: taking Lantus and Victoza together


Summary

Drug interactions are reported among people who take Lantus and Victoza together. This review analyzes the effectiveness and drug interactions between Lantus and Victoza. It is created by eHealthMe based on reports of 804 people who take the same drugs from FDA and social media, and is updated regularly.

You are not alone

Join a support group for people who take Lantus and Victoza >>>

Personalized health information

On eHealthMe you can find out what patients like me (same gender, age) reported their drugs and conditions on FDA and social media since 1977. Our tools are free and anonymous. 86 million people have used us. 300+ peer-reviewed medical journals have referenced our original studies. Start now >>>


Lantus

Lantus has active ingredients of insulin glargine recombinant. It is often used in diabetes. (latest outcomes from Lantus 61,386 users)

Victoza

Victoza has active ingredients of liraglutide. It is often used in type 2 diabetes. (latest outcomes from Victoza 15,243 users)

On Aug, 27, 2016

804 people who take Lantus, Victoza are studied.


Number of reports submitted per year:

Lantus and Victoza drug interactions.

Drug effectiveness over time:

Lantus:
  • < 1 month: 0.0% - (0 of 1 people)
  • 1 - 6 months: 33.0% - (1 of 3 people)
  • 6 - 12 months: 50.0% - (1 of 2 people)
  • 1 - 2 years: 50.0% - (2 of 4 people)
  • 2 - 5 years: 42.0% - (3 of 7 people)
  • 5 - 10 years: 50.0% - (2 of 4 people)
  • 10+ years: 0.0% - (0 of 1 people)
  • not specified: 0.0% - (0 of 0 people)
Victoza:
  • < 1 month: 100.0% - (1 of 1 people)
  • 1 - 6 months: 20.0% - (1 of 5 people)
  • 6 - 12 months: 50.0% - (4 of 8 people)
  • 1 - 2 years: 33.0% - (1 of 3 people)
  • 2 - 5 years: 50.0% - (2 of 4 people)
  • 5 - 10 years: 50.0% - (1 of 2 people)
  • 10+ years: 0.0% - (0 of 0 people)
  • not specified: 0.0% - (0 of 0 people)

Drug effectiveness by gender:

Lantus:
  • female: 11.0% - (1 of 9 people)
  • male: 61.0% - (8 of 13 people)
Victoza:
  • female: 40.0% - (4 of 10 people)
  • male: 46.0% - (6 of 13 people)

Drug effectiveness by age:

Lantus:
  • 0-1: 0.0% - (0 of 0 people)
  • 2-9: 0.0% - (0 of 0 people)
  • 10-19: 0.0% - (0 of 0 people)
  • 20-29: 0.0% - (0 of 0 people)
  • 30-39: 0.0% - (0 of 0 people)
  • 40-49: 25.0% - (1 of 4 people)
  • 50-59: 41.0% - (5 of 12 people)
  • 60+: 50.0% - (3 of 6 people)
Victoza:
  • 0-1: 0.0% - (0 of 0 people)
  • 2-9: 0.0% - (0 of 0 people)
  • 10-19: 0.0% - (0 of 0 people)
  • 20-29: 0.0% - (0 of 0 people)
  • 30-39: 0.0% - (0 of 0 people)
  • 40-49: 50.0% - (2 of 4 people)
  • 50-59: 53.0% - (7 of 13 people)
  • 60+: 16.0% - (1 of 6 people)

Most common drug interactions over time *:

< 1 month:
  • nausea
  • diarrhoea
  • abdominal pain
  • dehydration
  • pancreatitis acute
  • vomiting
  • pancreatitis
  • loss of consciousness
  • renal failure
  • abdominal pain upper
1 - 6 months:
  • pancreatitis
  • pancreatitis acute
  • nausea
  • pancreatic carcinoma
  • abdominal pain upper
  • dehydration
  • renal failure
  • decreased appetite
  • diarrhoea
  • nephrolithiasis
6 - 12 months:
  • pancreatitis acute
  • aspartate aminotransferase increased
  • decreased appetite
  • fatigue
  • pancreatitis
  • alanine aminotransferase increased
  • gamma-glutamyltransferase increased
  • glycosylated haemoglobin increased
  • dehydration
  • blood glucose decreased
1 - 2 years:
  • pancreatitis
  • myocardial infarction
  • angina unstable
  • paronychia
  • viral pericarditis
  • depression
  • diabetes mellitus inadequate control
  • dizziness
  • frequent or urgent urination
  • hyperlipidemia
2 - 5 years:
  • congestive cardiac failure aggravated
  • cystitis chronic
  • ear discomfort
  • fatigue - chronic
  • respiratory fatigue
  • weakness
  • renal failure acute
  • anaphylactic reaction
  • blood pressure increased
  • diabetic ketoacidosis
5 - 10 years:
  • hyperlipidemia
  • hypertension
  • insomnia
  • nausea
  • burping
  • chills
  • dementia
  • depression
  • diarrhea
  • frequent or urgent urination
10+ years:
  • confusional arousal
  • disorientation
  • dizziness
  • headache
not specified:
  • blood glucose increased
  • nausea
  • diarrhoea
  • weight decreased
  • blood glucose decreased
  • vomiting
  • decreased appetite
  • pancreatitis
  • headache
  • asthenia

Most common drug interactions by gender *:

female:
  • nausea
  • blood glucose increased
  • diarrhoea
  • vomiting
  • decreased appetite
  • pancreatitis
  • blood glucose decreased
  • headache
  • weight decreased
  • dehydration
male:
  • blood glucose increased
  • nausea
  • diarrhoea
  • weight decreased
  • blood glucose decreased
  • pancreatitis
  • renal failure acute
  • pancreatitis acute
  • vomiting
  • decreased appetite

Most common drug interactions by age *:

2-9:
  • disease recurrence
  • retinal vein thrombosis
10-19:
  • diabetic ketoacidosis
  • hypokalaemia
  • pancreatitis acute
  • vulvovaginal rash
  • acute generalised exanthematous pustulosis
20-29:
  • deep vein thrombosis
  • prostatitis
30-39:
  • oedema
  • weight increased
  • cardiac failure
  • decreased appetite
  • pulmonary oedema
  • blood glucose decreased
  • blood glucose increased
  • diabetic ketoacidotic hyperglycaemic coma
  • pancreatitis
  • vomiting
40-49:
  • nausea
  • diabetic ketoacidosis
  • pancreatitis
  • blood glucose increased
  • renal failure acute
  • headache
  • rash
  • vomiting
  • accidental overdose
  • anuria
50-59:
  • nausea
  • pancreatitis acute
  • blood glucose increased
  • diarrhoea
  • weight decreased
  • pancreatitis
  • vomiting
  • renal failure acute
  • decreased appetite
  • blood glucose decreased
60+:
  • nausea
  • blood glucose increased
  • diarrhoea
  • vomiting
  • decreased appetite
  • blood glucose decreased
  • dehydration
  • abdominal pain upper
  • weight decreased
  • asthenia

* Approximation only. Some reports may have incomplete information.

How to use the study: print a copy of the study and bring it to your health teams to ensure drug risks and benefits are fully discussed and understood.

Do you take Lantus and Victoza?

Can you answer these questions?

More questions for: Lantus, Victoza

You may be interested in these reviews

More reviews for: Lantus, Victoza

On eHealthMe, Lantus (insulin glargine recombinant) is often used to treat diabetes. Victoza (liraglutide) is often used to treat type 2 diabetes. Find out below the conditions the drugs are used for and how effective they are.

What is the drug used for and how effecitve is it:


NOTE: The study is based on active ingredients and brand name. Other drugs that have the same active ingredients (e.g. generic drugs) are NOT considered.

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only, and has not been supported by scientific studies or clinical trials unless otherwise stated. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

You may report adverse side effects to the FDA at http://www.fda.gov/medwatch/ or 1-800-FDA-1088 (1-800-332-1088).

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.